ARWR - Arrowhead Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

ARWR is currently covered by 13 analysts with an average price target of $97.92. This is a potential upside of $56.55 (136.69%) from yesterday's end of day stock price of $41.37.

Arrowhead Pharmaceuticals's activity chart (see below) currently has 310 price targets and 296 ratings on display. The stock rating distribution of ARWR is 77.78% BUY and 22.22% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 77.44% of the time, taking 390.86 days on average.

Highest price target for ARWR is $126, Lowest price target is $46, average price target is $97.92.

Most recent stock forecast was given by ERIC JOSEPH from CITI. First documented stock forecast 07-Feb-2014.

Currently out of the existing stock ratings of ARWR, 10 are a HOLD (22.22%), 35 are a BUY (77.78%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Sep-2026

$105

$63.63 (153.81%)

$108

5 days ago
(17-Nov-2026)

Buy Since 14-Jul-2026

$96

$54.63 (132.05%)

$98

9 days ago
(13-Nov-2026)

0/2 (0%)

$48.22 (100.92%)

Buy Since 12-May-2020

$100

$58.63 (141.72%)

$100

9 days ago
(13-Nov-2026)

21/23 (91.3%)

$52.22 (109.29%)

565

Buy Since 16-Sep-2020

$115

$73.63 (177.98%)

$115

1 months 7 days ago
(15-Oct-2026)

25/31 (80.65%)

$56.5 (96.58%)

544

Buy Since 17-Sep-2020

$120

$78.63 (190.07%)

$120

1 months 7 days ago
(15-Oct-2026)

14/37 (37.84%)

$61.5 (105.13%)

403

Show more analysts

Please expand the browser size to see the chart

What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?

On average it took 391 days for the stock forecasts to be reached, with an average price target met ratio of 77.44%.

Which analyst most recently updated their price target on ARWR (Arrowhead Pharmaceuticals)?

Eric Joseph

Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?

Eric Joseph works at CITI and has 7 price targets and 4 ratings on ARWR

Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?

Edward Tenthoff with the highest potential upside of $84.63

Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?

Eun Yang with the lowest potential downside of -$36.37
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?